Novel imaging reveals distinct atrophy subtypes in NMOSD and MS, suggesting implications for personalized treatment.
Motivation: The atrophy subtypes of neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) remain elusive. Goal(s): Identify shared and distinct atrophy subtypes in NMOSD and MS, using neuroimaging to explore their clinical significance and potential implications for tailored treatment strategies. Approach: 3D T1-weighted image derived structural measurements were used in a Subtype and Stage Inference model, to identify distinct brain and spinal cord atrophy subtypes of NMOSD and MS. Results: Both shared and distinct spatiotemporal brain and spinal cord atrophy subtypes were identified in AQP4+ NMOSD and MS, with distinct clinical and MRI features. Impact: These novel imaging subtypes in NMOSD and MS can help interpret disease heterogeneity, develop stratified management, and assess prognosis.
No takes yet. Share an insight, caveat, or question.
Zhuo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: